Kymera Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $603.1M
Liabilities Breakdown FY2022
Total Liabilities: $113.0M
Asset Breakdown
Total Assets: $603.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $68.4M | 11.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.3M | 2.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $521.4M | 86.4% |
Liabilities Breakdown
Total Liabilities: $113.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 3.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $108.6M | 96.2% |